Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 432

1.

Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.

El-Zammar OA, Zhang S, Katzenstein AL.

Diagn Mol Pathol. 2009 Sep;18(3):133-7. doi: 10.1097/PDM.0b013e3181857ea9.

PMID:
19704257
2.

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

Sasaki H, Shimizu S, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5.

PMID:
19058870
5.

Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.

Jeon YK, Sung SW, Chung JH, Park WS, Seo JW, Kim CW, Chung DH.

Lung Cancer. 2006 Dec;54(3):387-98. Epub 2006 Sep 29.

PMID:
17011067
6.

Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method.

Gupta R, Dastane AM, Forozan F, Riley-Portuguez A, Chung F, Lopategui J, Marchevsky AM.

Mod Pathol. 2009 Jan;22(1):128-33. doi: 10.1038/modpathol.2008.182. Epub 2008 Nov 7.

7.

Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.

Pinter F, Papay J, Almasi A, Sapi Z, Szabo E, Kanya M, Tamasi A, Jori B, Varkondi E, Moldvay J, Szondy K, Keri G, Dominici M, Conte P, Eckhardt S, Kopper L, Schwab R, Petak I.

J Mol Diagn. 2008 Mar;10(2):160-8. doi: 10.2353/jmoldx.2008.070125. Epub 2008 Feb 7.

8.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR.

J Clin Oncol. 2006 Sep 1;24(25):4170-6.

PMID:
16943533
9.

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.

Ilie MI, Hofman V, Bonnetaud C, Havet K, Lespinet-Fabre V, Coëlle C, Gavric-Tanga V, Vénissac N, Mouroux J, Hofman P.

Virchows Arch. 2010 Oct;457(4):483-95. doi: 10.1007/s00428-010-0963-z. Epub 2010 Aug 28.

PMID:
20803030
10.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.

BMC Cancer. 2008 Dec 6;8:363. doi: 10.1186/1471-2407-8-363.

11.

Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival.

Saxby AJ, Nielsen A, Scarlett CJ, Clarkson A, Morey A, Gill A, Smith RC.

Am J Surg Pathol. 2005 Sep;29(9):1125-34.

PMID:
16096400
12.

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

Press MF, Finn RS, Cameron D, Di Leo A, Geyer CE, Villalobos IE, Santiago A, Guzman R, Gasparyan A, Ma Y, Danenberg K, Martin AM, Williams L, Oliva C, Stein S, Gagnon R, Arbushites M, Koehler MT.

Clin Cancer Res. 2008 Dec 1;14(23):7861-70. doi: 10.1158/1078-0432.CCR-08-1056.

13.

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.

Lee HJ, Xu X, Choe G, Chung DH, Seo JW, Lee JH, Lee CT, Jheon S, Sung SW, Chung JH.

Lung Cancer. 2010 Jun;68(3):375-82. doi: 10.1016/j.lungcan.2009.07.014. Epub 2009 Aug 26.

PMID:
19712993
15.

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma.

Okuda K, Sasaki H, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.

J Cancer Res Clin Oncol. 2008 Oct;134(10):1105-11. doi: 10.1007/s00432-008-0384-4. Epub 2008 Apr 8.

PMID:
18392851
17.

EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.

Wei EX, Anga AA, Martin SS, Jackson JG, Nordberg ML, Herrera GA, Turbat-Herrera EA.

Mod Pathol. 2007 Sep;20(9):905-13. Epub 2007 Jul 20.

18.

Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.

Kim YT, Kim TY, Lee DS, Park SJ, Park JY, Seo SJ, Choi HS, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH.

Lung Cancer. 2008 Jan;59(1):111-8. Epub 2007 Sep 29.

PMID:
17904685
19.

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.

Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH.

Histopathology. 2008 May;52(6):738-46. doi: 10.1111/j.1365-2559.2008.03021.x. Epub 2008 Apr 5.

PMID:
18397279
20.

HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Uehara T, Fujimoto M, Tsuruyama T, Date H, Haga H.

Lung Cancer. 2014 Sep;85(3):373-8. doi: 10.1016/j.lungcan.2014.06.007. Epub 2014 Jul 7.

PMID:
25047676

Supplemental Content

Support Center